Ruggie Capital Group’s AbbVie ABBV Stock Holding History

Ruggie Capital Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$46K	Hold	530	–	–	2.38%	13
2020 Q2	$52K	Hold	530	–	–	4.28%	6
2020 Q1	$40K	Hold	530	–	–	4.18%	8
2019 Q4	$47K	Buy	+530	New	+$44K	2.76%	18
2019 Q3	–	Sell	-530	Closed	-$39K	–	96
2019 Q2	$39K	Hold	530	–	–	0.07%	75
2019 Q1	$43K	Sell	530 -293	-36%	-$24K	0.05%	108
2018 Q4	$76K	Buy	823 +293	+55%	+$25.8K	0.03%	142
2018 Q3	$50K	Sell	530 -600	-53%	-$56.9K	0.03%	133
2018 Q2	$104K	Hold	1,130	–	–	0.05%	144
2018 Q1	$107K	Hold	1,130	–	–	0.06%	107
2017 Q4	$109K	Hold	1,130	–	–	0.07%	100
2017 Q3	$100K	Hold	1,130	–	–	0.06%	92
2017 Q2	$82K	Hold	1,130	–	–	0.06%	103
2017 Q1	$74K	Buy	1,130 +600	+113%	+$37.7K	0.06%	95
2016 Q4	$33K	Hold	530	–	–	0.04%	82
2016 Q3	$33K	Hold	530	–	–	0.03%	98
2016 Q2	$33K	Sell	530 -340	-39%	-$20.7K	0.03%	109
2016 Q1	$50K	Buy	+870	New	+$48.5K	0.05%	79
2015 Q4	–	Sell	-589	Closed	-$31K	–	7
2015 Q3	$31K	Sell	589 -14	-2%	-$911	0.03%	92
2015 Q2	$41K	Buy	603 +14	+2%	+$914	0.03%	94
2015 Q1	$34K	Sell	589 -407	-41%	-$24.6K	0.04%	81
2014 Q4	$65K	Buy	+996	New	+$62.8K	0.06%	68

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Ruggie Capital Group's ABBV Position: Q3 2020 in Review

Ruggie Capital Group held its AbbVie (ABBV) position steady in Q3 2020 at 530 shares worth $46K. The position accounts for 2.38% of the portfolio, ranked #13.

Ruggie Capital Group first reported a position in ABBV in Q4 2014 and has held it in 22 quarters since. The position peaked at $109K in Q4 2017. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

Ruggie Capital Group held 530 shares of AbbVie worth $46K as of Q3 2020.
Ruggie Capital Group left its AbbVie share count unchanged in Q3 2020.
AbbVie made up 2.38% of Ruggie Capital Group's portfolio in Q3 2020, its #13 holding.
Ruggie Capital Group first reported a position in AbbVie in Q4 2014 and has held it in 22 quarters since.
Ruggie Capital Group's AbbVie position peaked at $109K in Q4 2017.
2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Ruggie Capital Group's 13F filing for Q3 2020, filed 29 Oct 2020.